Singapore markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
76.94+0.98 (+1.29%)
As of 10:28AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 163.60B
Enterprise value 194.40B
Trailing P/E 27.25
Forward P/E 10.09
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.63
Price/book (mrq)5.18
Enterprise value/revenue 4.14
Enterprise value/EBITDA 10.14

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 313.14%
S&P500 52-week change 3-12.09%
52-week high 380.59
52-week low 353.22
50-day moving average 376.14
200-day moving average 366.97

Share statistics

Avg vol (3-month) 314.68M
Avg vol (10-day) 311.71M
Shares outstanding 52.13B
Implied shares outstanding 6N/A
Float 82.13B
% held by insiders 10.07%
% held by institutions 179.24%
Shares short (14 Jun 2022) 434.46M
Short ratio (14 Jun 2022) 42.47
Short % of float (14 Jun 2022) 41.62%
Short % of shares outstanding (14 Jun 2022) 41.62%
Shares short (prior month 12 May 2022) 432.18M

Dividends & splits

Forward annual dividend rate 42.16
Forward annual dividend yield 42.84%
Trailing annual dividend rate 32.06
Trailing annual dividend yield 32.71%
5-year average dividend yield 42.94
Payout ratio 473.05%
Dividend date 331 Jul 2022
Ex-dividend date 429 Jun 2022
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 13.31%
Operating margin (ttm)22.16%

Management effectiveness

Return on assets (ttm)6.04%
Return on equity (ttm)18.08%

Income statement

Revenue (ttm)46.96B
Revenue per share (ttm)21.36
Quarterly revenue growth (yoy)5.20%
Gross profit (ttm)37.05B
Net income avi to common (ttm)6.25B
Diluted EPS (ttm)2.82
Quarterly earnings growth (yoy)-36.80%

Balance sheet

Total cash (mrq)15.2B
Total cash per share (mrq)7.14
Total debt (mrq)45.99B
Total debt/equity (mrq)145.35
Current ratio (mrq)1.32
Book value per share (mrq)14.83

Cash flow statement

Operating cash flow (ttm)16.2B
Levered free cash flow (ttm)14.86B